Adial Pharmaceuticals's market cap is currently $4.98M. The company's EPS TTM is $-4.31; its P/E ratio is ―; Adial Pharmaceuticals is scheduled to report earnings on March 27, 2025, and the estimated EPS forecast is $-0.32. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ -564.00	$ -60.50K	$ -55.11K	$ -564.00	$ -565.00
Operating Income	$ -6.89M	$ -13.32M	$ -19.29M	$ -10.93M	$ -8.24M
EBITDA	$ -7.00M	$ -13.32M	$ -19.46M	$ -10.93M	$ -8.15M
Net Income	$ -7.00M	$ -12.73M	$ -19.42M	$ -10.86M	$ -8.59M
Balance Sheet
Cash & Short-Term Investments	$ 2.83M	$ 4.00M	$ 6.06M	$ 4.40M	$ 6.78M
Total Assets	$ 4.74M	$ 5.73M	$ 7.47M	$ 5.49M	$ 7.68M
Total Debt	$ 0.00	$ 207.38K	$ 256.96K	$ 0.00	$ 0.00
Net Debt	$ -2.83M	$ -3.79M	$ -5.81M	$ -4.40M	$ -6.78M
Total Liabilities	$ 653.08K	$ 2.46M	$ 3.97M	$ 1.51M	$ 539.05K
Stockholders' Equity	$ 4.08M	$ 3.28M	$ 3.51M	$ 3.99M	$ 7.14M
Cash Flow
Free Cash Flow	$ 0.00	$ -11.19M	$ -12.01M	$ -7.63M	$ -6.34M
Operating Cash Flow	$ -6.81M	$ -11.19M	$ -11.95M	$ -7.63M	$ -6.34M
Investing Cash Flow	$ 1.50M	$ 0.00	$ -34.02K	$ -350.00K	$ 0.00
Financing Cash Flow	$ 4.13M	$ 9.13M	$ 13.64M	$ 5.61M	$ 9.25M

Currency in USD

Adial Pharmaceuticals Earnings and Revenue History

Income Statement >

Adial Pharmaceuticals Debt to Assets

Balance Sheet >

Adial Pharmaceuticals Cash Flow

Cash Flow >

Adial Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing